Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) FCF Margin (2016 - 2020)

Historic FCF Margin for Forte Biosciences (FBRX) over the last 5 years, with Q1 2020 value amounting to 378.97%.

  • Forte Biosciences' FCF Margin rose 1983234100.0% to 378.97% in Q1 2020 from the same period last year, while for Dec 2020 it was 2436.9%, marking a year-over-year increase of 105841300.0%. This contributed to the annual value of 8147.22% for FY2019, which is 79452000.0% down from last year.
  • Latest data reveals that Forte Biosciences reported FCF Margin of 378.97% as of Q1 2020, which was up 1983234100.0% from 8244.44% recorded in Q4 2019.
  • Forte Biosciences' 5-year FCF Margin high stood at 177700.0% for Q2 2019, and its period low was 197944.44% during Q1 2019.
  • Moreover, its 5-year median value for FCF Margin was 4100.0% (2019), whereas its average is 39712.06%.
  • In the last 5 years, Forte Biosciences' FCF Margin crashed by -1449039500bps in 2018 and then soared by 2000000000bps in 2019.
  • Quarter analysis of 5 years shows Forte Biosciences' FCF Margin stood at 1486.21% in 2016, then crashed by -6485bps to 94900.0% in 2017, then crashed by -45bps to 137944.44% in 2018, then surged by 94bps to 8244.44% in 2019, then soared by 105bps to 378.97% in 2020.
  • Its FCF Margin stands at 378.97% for Q1 2020, versus 8244.44% for Q4 2019 and 4100.0% for Q3 2019.